Wellington Management Group LLP 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 10:44 am Sale | 2025-03-31 | 13G | Nurix Therapeutics, Inc. NRIX | Wellington Management Group LLP | 3,188,742 4.200% | -293,363 (-8.42%) | Filing |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX | Wellington Management Group LLP | 3,482,105 5.410% | 2,319,789 (+199.58%) | Filing |
| 2022-02-04 09:21 am Sale | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Wellington Management Group LLP | 1,162,316 2.610% | -1,285,268 (-52.51%) | Filing |
| 2021-02-04 09:51 am Sale | 2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Wellington Management Group LLP | 2,447,584 6.300% | -1,628,396 (-39.95%) | Filing |